Define range intervals using parentheses.
E.g. C7H(10-14)O(0-4)

to
±
(example: 123 ± 1)

to
±

to
±
 

to
±
 
Search Hits Limit:
Single/Multi-component
Isotopically Labeled
Additional Filters

Found 40 results

Search term: MF = 'C_{26}H_{26}F_{6}N_{4}O_{3}'
12
IDStructureMolecular FormulaMolecular Weight# of Data Sources# of References# of PubMed# of RSC
28536138

3 of 3 defined stereocentres - 3/3 defined
InChI=1/C26H26F6N4O3/c1-36-19-10-6-5-9-18(19)20(15-7-3-2-4-8-15)34-22(24(36)39)35-23(38)17(12-14-26(30,31)32)16(21(33)37)11-13-25(27,28)29/h2-10,16-17,22H,11-14H2,1H3,(H2,33,37)(H,35,38)/t16-,17+,22+/m0/s1
C26H26F6N4O3556.5001363300
21543311
InChI=1/C26H26F6N4O3/c27-25(28,29)20-7-5-18(6-8-20)24(37)36(11-2-10-35-13-15-38-16-14-35)12-9-22-33-23(34-39-22)19-3-1-4-21(17-19)26(30,31)32/h1,3-8,17H,2,9-16H2
C26H26F6N4O3556.50017600
22584192
InChI=1/C26H26F6N4O3/c1-2-33-21(37)15-35-16-36(20-6-4-3-5-7-20)24(23(35)39)8-10-34(11-9-24)22(38)17-12-18(25(27,28)29)14-19(13-17)26(30,31)32/h3-7,12-14H,2,8-11,15-16H2,1H3,(H,33,37)
C26H26F6N4O3556.50013200
76773144

3 of 3 defined stereocentres - 3/3 defined
InChI=1/C26H26F6N4O3/c1-14-5-4-6-15(13-14)20-18-7-2-3-8-19(18)34-24(39)22(35-20)36-23(38)17(10-12-26(30,31)32)16(21(33)37)9-11-25(27,28)29/h2-8,13,16-17,22H,9-12H2,1H3,(H2,33,37)(H,34,39)(H,36,38)/t16-,17+,22+/m0/s1
C26H26F6N4O3556.50013300
76775754

3 of 3 defined stereocentres - 3/3 defined
InChI=1/C26H26F6N4O3/c1-14-6-5-9-18-19(14)35-24(39)22(34-20(18)15-7-3-2-4-8-15)36-23(38)17(11-13-26(30,31)32)16(21(33)37)10-12-25(27,28)29/h2-9,16-17,22H,10-13H2,1H3,(H2,33,37)(H,35,39)(H,36,38)/t16-,17+,22+/m0/s1
C26H26F6N4O3556.50013300
76780936

3 of 3 defined stereocentres - 3/3 defined
InChI=1/C26H26F6N4O3/c1-14-6-8-15(9-7-14)20-18-4-2-3-5-19(18)34-24(39)22(35-20)36-23(38)17(11-13-26(30,31)32)16(21(33)37)10-12-25(27,28)29/h2-9,16-17,22H,10-13H2,1H3,(H2,33,37)(H,34,39)(H,36,38)/t16-,17+,22+/m0/s1
C26H26F6N4O3556.50013300
76785947

3 of 3 defined stereocentres - 3/3 defined
InChI=1/C26H26F6N4O3/c1-14-6-2-3-7-15(14)20-18-8-4-5-9-19(18)34-24(39)22(35-20)36-23(38)17(11-13-26(30,31)32)16(21(33)37)10-12-25(27,28)29/h2-9,16-17,22H,10-13H2,1H3,(H2,33,37)(H,34,39)(H,36,38)/t16-,17+,22+/m0/s1
C26H26F6N4O3556.50013300
3638327
InChI=1/C26H26F6N4O3/c1-33(2)21(37)15-35-16-36(20-6-4-3-5-7-20)24(23(35)39)8-10-34(11-9-24)22(38)17-12-18(25(27,28)29)14-19(13-17)26(30,31)32/h3-7,12-14H,8-11,15-16H2,1-2H3
C26H26F6N4O3556.5000591999993200
7983539
InChI=1/C26H26F6N4O3/c1-17-22(23(34-39-17)18-6-3-2-4-7-18)24(37)33-10-5-11-35-12-14-36(15-13-35)20-16-19(27)8-9-21(20)38-26(31,32)25(28,29)30/h2-4,6-9,16H,5,10-15H2,1H3,(H,33,37)
C26H26F6N4O3556.50012100
8004891
InChI=1/C26H26F6N4O3/c1-17-22(23(34-39-17)18-6-3-2-4-7-18)24(37)33-10-5-11-35-12-14-36(15-13-35)20-9-8-19(27)16-21(20)38-26(31,32)25(28,29)30/h2-4,6-9,16H,5,10-15H2,1H3,(H,33,37)
C26H26F6N4O3556.50012100
8004892
InChI=1/C26H26F6N4O3/c1-17-22(23(34-39-17)18-7-9-19(27)10-8-18)24(37)33-11-4-12-35-13-15-36(16-14-35)20-5-2-3-6-21(20)38-26(31,32)25(28,29)30/h2-3,5-10H,4,11-16H2,1H3,(H,33,37)
C26H26F6N4O3556.50012100
8004893
InChI=1/C26H26F6N4O3/c1-17-22(23(34-39-17)18-6-4-7-19(27)16-18)24(37)33-10-5-11-35-12-14-36(15-13-35)20-8-2-3-9-21(20)38-26(31,32)25(28,29)30/h2-4,6-9,16H,5,10-15H2,1H3,(H,33,37)
C26H26F6N4O3556.50012100
8069595
InChI=1/C26H26F6N4O3/c1-17-22(23(34-39-17)18-7-2-3-8-19(18)27)24(37)33-11-6-12-35-13-15-36(16-14-35)20-9-4-5-10-21(20)38-26(31,32)25(28,29)30/h2-5,7-10H,6,11-16H2,1H3,(H,33,37)
C26H26F6N4O3556.50012100
8295774
InChI=1/C26H26F6N4O3/c1-16-7-5-6-8-21(16)39-22-20(14-33-24(34-22)38-10-9-35(2)3)23(37)36(4)15-17-11-18(25(27,28)29)13-19(12-17)26(30,31)32/h5-8,11-14H,9-10,15H2,1-4H3
C26H26F6N4O3556.50012100
9701686

3 of 3 defined stereocentres - 3/3 defined
InChI=1/C26H26F6N4O3/c1-16(18-10-20(25(27,28)29)12-21(11-18)26(30,31)32)39-14-23(19-6-4-3-5-7-19)8-9-24(13-33-23,17(2)37)36-15-34-35-22(36)38/h3-7,10-12,15-16,33H,8-9,13-14H2,1-2H3,(H,35,38)/t16-,23-,24+/m1/s1
C26H26F6N4O3556.50012100
9788505

3 of 3 defined stereocentres - 3/3 defined
InChI=1/C26H26F6N4O3/c1-17(18-10-20(25(27,28)29)12-21(11-18)26(30,31)32)39-14-23(19-6-4-3-5-7-19)8-9-24(13-33-23,22(37)38-2)36-15-34-35-16-36/h3-7,10-12,15-17,33H,8-9,13-14H2,1-2H3/t17-,23-,24-/m1/s1
C26H26F6N4O3556.50012100
95701832

0 of 2 defined stereocentres - 0/2 defined
InChI=1/C26H26F6N4O3/c1-36-19-10-6-5-9-18(19)20(15-7-3-2-4-8-15)34-22(24(36)39)35-23(38)17(12-14-26(30,31)32)16(21(33)37)11-13-25(27,28)29/h2-10,16-17,39H,11-14H2,1H3,(H2,33,37)(H,35,38)
C26H26F6N4O3556.50011100
120796650

0 of 2 defined stereocentres - 0/2 defined
InChI=1/C26H26F6N4O3/c1-3-4-10-21(23(38)33-19-12-17(25(27,28)29)11-18(13-19)26(30,31)32)34-22(37)14-20(16-8-6-5-7-9-16)24-36-35-15(2)39-24/h5-9,11-13,20-21H,3-4,10,14H2,1-2H3,(H,33,38)(H,34,37)
C26H26F6N4O3556.50011100
68025205

1 of 3 defined stereocentres - 1/3 defined
InChI=1/C26H26F6N4O3/c1-36-19-10-6-5-9-18(19)20(15-7-3-2-4-8-15)34-22(24(36)39)35-23(38)17(12-14-26(30,31)32)16(21(33)37)11-13-25(27,28)29/h2-10,16-17,22H,11-14H2,1H3,(H2,33,37)(H,35,38)/t16-,17?,22?/m1/s1
C26H26F6N4O3556.50011100
12

Advertisement